Edaravone inhibits the disease activity in rheumatoid arthritis - PubMed (original) (raw)

Case Reports

Edaravone inhibits the disease activity in rheumatoid arthritis

Kaoru Arii et al. J Clin Pharm Ther. 2006 Apr.

Abstract

A male patient with rheumatoid arthritis (RA) developed acute stroke and was treated with the free radical scavenger, edaravone. Polyarthralgia improved with a reduction in serum C-reactive protein concentration soon after the start of edaravone administration. The disease activity score 28 (DAS28) also decreased. Edaravone appears to be effective for the control of RA. The usefulness of this potentially novel therapeutic agent should be tested in a well designed randomized controlled trial.

PubMed Disclaimer

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources